* Apollon Inc., of Malvern, Pa., received a patent, licensed from the University of Pennsylvania and the Wistar Institute, for a method of DNA-based genetic immunization. The patent relates to a gene delivery and immunization technology under development by Apollon.

* Celtrix Pharmaceuticals Inc., of Santa Clara, Calif., received a patent covering the intravenous, intramuscular, intraperitoneal and intranasal administration of SomatoKine for treatment of catabolic wasting conditions. SomatoKine is a recombinant form of insulin-like growth factor and its binding protein, BP3.